Autism may have two distinct subtypes that vary by brain activity

The suggestion that autism may consist of distinct subtypes based on brain activity could reshape how we understand and treat the condition. If confirmed, this finding challenges the long-held view of autism as a single, monolithic disorder, opening the door to more targeted interventions. Historically, autism research has focused on broad diagnostic categories rather than individualized differences in neural wiring, but emerging brain imaging studies suggest that connectivity patterns may vary significantly among autistic individuals. This could explain why responses to therapies differ so widely—some benefit from behavioral interventions, while others may respond better to sensory or pharmacological approaches. By recognizing these subtypes, clinicians might finally move beyond one-size-fits-all treatments toward precision medicine for autism. The implications extend beyond treatment. If autism is not a uniform condition, how does this align with evolving diagnostic criteria? The DSM-5 already shifted toward a spectrum-based approach, but if brain activity patterns define distinct subtypes, future editions might incorporate neurobiological markers alongside behavioral observations. This could also influence public perception, where autism is often framed as a single experience rather than a diverse set of conditions with shared traits but different underlying mechanisms. The shift could reduce stigma by highlighting the uniqueness of each individual’s brain rather than treating autism as a homogenous challenge. However, major questions remain. Are these subtypes stable over a person’s lifetime, or do they shift with age and development? Could environmental factors, like early intervention or sensory experiences, influence which subtype a person falls into? And if brain connectivity patterns define these subtypes, what role do genetics play in shaping them? Large-scale longitudinal studies will be needed to answer these questions, and researchers will have to grapple with the ethical implications of subtyping a condition that many advocates argue should not be fragmented without cause. Ultimately, this research fits into a broader trend in neuroscience, where conditions once thought to be singular are being redefined by brain-based distinctions. From Alzheimer’s to depression, scientists are uncovering subtypes that could lead to more effective, personalized care. For autism, this could be a turning point—one that moves the field from broad generalizations to a nuanced understanding of the human brain.